Skip to main content

Division of Endocrinology and Metabolism

Welcome to the Division of Endocrinology and Metabolism, providing the very best in patient-centered care, in a caring and compassionate environment. Our physicians are faculty members in the Department of Medicine at the UNC School of Medicine, applying the newest research and therapies to patients with diabetes, endocrine and metabolic diseases. We continually strive to improve the quality of patient care with our comprehensive approach, teaching the science and best practices of endocrine care.

Our physicians provide outpatient and inpatient consultative care for patients with diagnostic or treatment issues, for endocrine and metabolic diseases. Learn more about the patient care we provide and our clinic.

The Division has a long tradition of excellence in basic science, and translational and clinical research. Faculty research focuses on new modalities for treatment of diabetes and obesity, the factors that are responsible for improving bone mineral density, molecular mechanisms of obesity, and lipid metabolism, particularly as it relates to insulin secretion.

Our greatest teaching efforts focus on clinical training of students (future doctors, nurses, dietitians, physician assistants, and researchers). This includes the interns and residents who will be the primary care doctors and specialists of the future, and in particular, the fellows who are fully trained doctors preparing for a future career in endocrinology. Fellows are also full members of the division, and with support from faculty, fully participate in clinical care, teaching and research.  We also provide continuing education for physicians throughout the UNC Health Care System, through national and international programs.

Thank you for your interest in our programs, and please contact us to learn more. We look forward to serving you.


Endocrinology & Metabolism News

  • john-buse

    Buse Explains Type 1.5 Diabetes

    Diabetes as we know it is typically organized into two neat categories: type 1 and type 2. In type 1 diabetes, antibodies from your own immune system destroy the cells which produce insulin. The disease starts suddenly and is usually diagnosed in children. Type 2 diabetes most often develops in adults as a result of … Continued

  • john-buse

    What’s Best for Diabetes After Metformin?

    Results of the five-year GRADE trial, designed to understand the best second-line agent for patients with type 2 diabetes already taking metformin, were reported at the virtual American Diabetes Association (ADA) 81st Scientific Sessions and published in Medscape Medical News. Researchers found the injectable drugs Lantus (glargine) and Victoza (liraglutide) outperformed the pills Amaryl (glimepiride) and … Continued

  • sue-kirkman

    Trial Results Show Two Medications Most Effective in Lowering Blood Glucose Levels in Type 2 Diabetes Patients

    Two medications, liraglutide and insulin, were better at keeping A1C (a measurement of average blood glucose) levels less than 7% in recent GRADE study. The UNC Diabetes Care Center, lead by site principal investigator Sue Kirkman, MD, professor of medicine, in the division of endocrinology and metabolism, was one of the 37 sites to be … Continued

More News